-
Citi Reiterates Buy Rating on Bruker (BRKR)
-
Citi Reiterates Buy Rating on Bruker (BRKR)
-
Bruker Corporation to Present at Upcoming Investor Conferences
-
Citi Closes 90-Day Upside Catalyst Watch on Bruker (BRKR)
-
Citi Opens Upside 90-Day Catalyst Watch on Bruker (BRKR)
-
20 Growth Stocks to Consider on a Pullback - Citi
-
Citi Adjusts 2023 N. America Focus List, Adds Vulcan Materials (VMC), Removes 4 Other Biotech Names
-
Bruker Corporation to Present at Investor Conferences
-
UPDATE: Citi Upgrades Bruker (BRKR) to Buy
-
Bruker (BRKR) Investor Meetings Hint At Margin Expansion - Citi
-
Notable Analyst Rating Changes 5/5: (SRI) (TEAR) (CLR) Upgraded; (GOLD) (SALT) (AAP) Downgraded
-
Notable Analyst Rating Changes 11/12: (M) (GALE) (DVN) Upgraded; (SUNE) (BSBR) (PWR) Downgraded
-
Pre-Open Stock Movers 12/18: (ZAGG) (OVAS) (TTPH) (RAD) Higher; (MLHR) (KEX) (BRKR) Lower (more
-
Citi Starts Bruker (BRKR) at Buy
-
Notable Analyst Rating Changes 07/08: (GRPN) (GES) (WDR) Upgraded; (TFM) (HOS) (ZBRA) Downgraded
-
Morning Movers 07/24: (SRPT) (SANM) (CYNO) (DNDN) Higher; (DV) (GNTX) (WBMD) (BRKR) Lower
-
Morning Movers 05/01: (CEBK) (PLXT) (IPSU) (PFCB) (CAR) Higher; (PBY) (ECOL) (MERU) Lower
-
Deutsche Bank Upgraded the Life Science Tools Sector to Outperform (TMO, LIFE, ILMN)
-
Matrix USA Rating Changes 3/4

